Physician profile
Thomas K John
NPI 1104021427
$58,736.43
in general payments reported to CMS, 2019-2025
16 companies · $1,163 in 2025
The $1,163 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $24K · 2021: $11K · 2022: $244 · 2023: $366 · 2024: $259 · 2025: $1,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $53,473.57 | 2019-2025 | Persona |
| Stryker Corporation | $3,633.42 | 2019-2025 | Mako, Insignia, Triathlon |
| Medical Device Business Services, INC. | $879.71 | 2019 | |
| Next Science LLC | $149.06 | 2024 | Blastx, Xperience, Surgx |
| Heraeus Medical, LLC. | $134.05 | 2019-2021 | |
| Depuy Synthes Sales INC. | $109.66 | 2019-2020 | |
| Pacira Therapeutics, INC. | $68.59 | 2019 | |
| Bioventus LLC | $64.27 | 2019-2025 | Durolane |
| Smith+Nephew, INC. | $46.34 | 2020-2021 | |
| Kerecis Limited | $38.18 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Acera Surgical, INC. | $32.94 | 2025 | Restrata Wound Matrix |
| Avanir Pharmaceuticals, INC. | $27.88 | 2019 | |
| Horizon Therapeutics Plc | $27.19 | 2019-2020 | |
| Ethicon US, LLC | $19.80 | 2025 | Stratafix, Ethicon, Vistaseal |
| Vertex Pharmaceuticals Incorporated | $17.91 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.